Rhabdomyosarcoma, Embryonal

Below you will find more information about Rhabdomyosarcoma, Embryonal from Medigest. If you believe that you are suffering from any of the symptoms of Rhabdomyosarcoma, Embryonal it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Rhabdomyosarcoma, Embryonal and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Rhabdomyosarcoma, Embryonal comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.


Embryonal rhabdomyosarcoma, also alternatively called sarcoma botryoides, is a rare form of vaginal cancer affecting female infants and children under 8 years old.


In the past, embryonal rhabdomyosarcoma was almost invariably fatal and treated with radical surgery. However, a new approach in the form of multi-drug chemotherapy regimens (with or without radiation therapy) has demonstrated some proven efficacy.

Symptoms and Signs

The most common clinical symptom of embryonal rhabdomyosarcoma is vaginal bleeding. However, this symptom is not unique to embryonal rhabdomyosarcoma and may be attributed to other types of vaginal cancers. An important diagnostic step is, therefore, eliminating other possible causes of vaginal bleeding. On average, symptoms of embryonal rhabdomyosarcoma present at age 3. While associated mostly in young children, isolated cases of the disease occurring in adult females have also been reported.

Discuss Rhabdomyosarcoma, Embryonal in our forums

Discuss Rhabdomyosarcoma, Embryonal with other members of Medigest in our forums.